Protalix BioTherapeutics
PLX
$1.13
Share price
-0.88%
Change (1 day)
-47.20%
Change (1 year)
Categories
Protalix BioTherapeutics (PLX) - Total assets
Total assets on the balance sheet as of March 2024 : $89.82 M
According to Protalix BioTherapeutics 's latest financial reports the company's total assets are $89.82 M. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Protalix BioTherapeutics - Total assets on balance sheet (from 2001 to 2024)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $84.43 M | 51.35% |
| 2022-12-31 | $55.78 M | -24.27% |
| 2021-12-31 | $73.66 M | 8.44% |
| 2020-12-31 | $67.93 M | 49.66% |
| 2019-12-31 | $45.39 M | -25.75% |
| 2018-12-31 | $61.13 M | -15.35% |
| 2017-12-31 | $72.21 M | -12.2% |
| 2016-12-31 | $82.24 M | -15.43% |
| 2015-12-31 | $97.25 M | 24.12% |
| 2014-12-31 | $78.35 M | -30.86% |
| 2013-12-31 | $0.11 B | 43.96% |
| 2012-12-31 | $78.72 M | 51.97% |
| 2011-12-31 | $51.8 M | -19.97% |
| 2010-12-31 | $64.72 M | -34.4% |
| 2009-12-31 | $98.67 M | 94.19% |
| 2008-12-31 | $50.81 M | -25.43% |
| 2007-12-31 | $68.13 M | 152.47% |
| 2006-12-31 | $26.98 M | 273.54% |
| 2005-12-31 | $7.22 M | 1176.5% |
| 2004-12-31 | $0.56 M | -22.92% |
| 2003-12-31 | $0.73 M | -16.11% |
| 2002-12-31 | $0.87 M | -14.46% |
| 2001-12-31 | $1.02 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $221.09 B | 246,039.72% | 🇺🇸 USA |
 Neurocrine Biosciences
NBIX | $3.47 B | 3,765.74% | 🇺🇸 USA |
 Amicus Therapeutics
FOLD | $0.72 B | 703.55% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $42.77 B | 47,518.15% | 🇮🇱 Israel |